ABCB1 and acute myeloid leukemia: ABCB1 (3435G > A, rs1045642) GG genotype was associated with increased likelihood of complete remission when treated with cytarabine and idarubicin in AML patients as compared to AA + AG genotypes,26 other study showed for ABCB1 (3435G > A, rs1045642) AA + AG genotypes were associated with increased overall survival when treated with cytarabine in AML patients as compared to genotype GG.27